tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
De-Risked LOTUS Phase 2 Design and Monthly Dosing Support Reiterated Buy on Avalo Therapeutics
PremiumRatingsDe-Risked LOTUS Phase 2 Design and Monthly Dosing Support Reiterated Buy on Avalo Therapeutics
2M ago
Avalo Therapeutics Highlights AVTX-009 Progress in HS
Premium
Company Announcements
Avalo Therapeutics Highlights AVTX-009 Progress in HS
2M ago
Avalo Therapeutics files $750M mixed securities shelf
Premium
The Fly
Avalo Therapeutics files $750M mixed securities shelf
2M ago
Avalo Completes Enrollment for Phase 2 LOTUS Trial
PremiumCompany AnnouncementsAvalo Completes Enrollment for Phase 2 LOTUS Trial
4M ago
Avalo Therapeutics completes enrollment in Phase 2 LOTUS trial
Premium
The Fly
Avalo Therapeutics completes enrollment in Phase 2 LOTUS trial
4M ago
Avalo Therapeutics Advances in Hidradenitis Suppurativa Treatment with AVTX-009 Study
Premium
Company Announcements
Avalo Therapeutics Advances in Hidradenitis Suppurativa Treatment with AVTX-009 Study
4M ago
Avalo Therapeutics appoints Boyd as CBO, Ivanowicz as SVP, Human Resources
PremiumThe FlyAvalo Therapeutics appoints Boyd as CBO, Ivanowicz as SVP, Human Resources
5M ago
Avalo Therapeutics Appoints Kevin Lind to Board
Premium
Company Announcements
Avalo Therapeutics Appoints Kevin Lind to Board
6M ago
Avalo Therapeutics appoints Kevin Lind to board of directors
Premium
The Fly
Avalo Therapeutics appoints Kevin Lind to board of directors
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100